Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+8.9%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$7.67B
AUM Growth
+$1.53B
(+25%)
Cap. Flow
+$1.02B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
20.43%
Holding
1,048
New
63
Increased
792
Reduced
112
Closed
32
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$28.6M |
| 2 |
RTX Corp
RTX
|
$24.7M |
| 3 |
Apple
AAPL
|
$24.4M |
| 4 |
Procter & Gamble
PG
|
$22M |
| 5 |
Walt Disney
DIS
|
$21.6M |
Top Sells
| 1 |
iShares MSCI Saudi Arabia ETF
KSA
|
$21.6M |
| 2 |
Lamb Weston
LW
|
$14.9M |
| 3 |
3M
MMM
|
$12.9M |
| 4 |
CELG
Celgene Corp
CELG
|
$12.2M |
| 5 |
MSCI
MSCI
|
$10M |
Sector Composition
| 1 | Technology | 19.32% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 12.78% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Amicus Therapeutics
FOLD
$2.47B
| $136K | ﹤0.01% |
14,795
+2,452
| +20% | +$22.5K |
|
|
HIMX
927
Himax Technologies
HIMX
$1.45B
| $136K | ﹤0.01% |
44,430
-2,348
| -5% | -$7.19K |
|
928
Xencor
XNCR
$597M
| $133K | ﹤0.01% |
3,813
-538
| -12% | -$18.8K |
|
|
SNR
929
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $132K | ﹤0.01% |
17,282
| – | – |
|
930
Toyota
TM
$258B
| $131K | ﹤0.01% |
930
-14
| -1% | -$1.97K |
|
931
Telecom Argentina
TEO
$3.61B
| $130K | ﹤0.01% |
12,010
| – | – |
|
|
GOOD
932
Gladstone Commercial Corp
GOOD
$617M
| $129K | ﹤0.01% |
6,022
-126
| -2% | -$2.7K |
|
933
Vericel Corp
VCEL
$1.7B
| $128K | ﹤0.01% |
7,438
-1,824
| -20% | -$31.4K |
|
|
UMH
934
UMH Properties
UMH
$1.28B
| $126K | ﹤0.01% |
8,089
| – | – |
|
|
WSR
935
Whitestone REIT
WSR
$666M
| $122K | ﹤0.01% |
9,193
+1,918
| +26% | +$25.5K |
|
|
APTS
936
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $122K | ﹤0.01% |
9,391
-166
| -2% | -$2.16K |
|
|
DRNA
937
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $122K | ﹤0.01% |
5,756
-6,584
| -53% | -$140K |
|
938
Sangamo Therapeutics
SGMO
$160M
| $121K | ﹤0.01% |
14,679
+202
| +1% | +$1.67K |
|
939
CRISPR Therapeutics
CRSP
$4.8B
| $120K | ﹤0.01% |
2,013
-1,642
| -45% | -$97.9K |
|
|
RVI
940
DELISTED
Retail Value Inc. Common Shares
RVI
| $118K | ﹤0.01% |
35,581
| – | – |
|
941
Adeia
ADEA
$1.69B
| $117K | ﹤0.01% |
24,468
+7,662
| +46% | +$36.6K |
|
942
Iridium Communications
IRDM
$2.61B
| $115K | ﹤0.01% |
4,622
-29
| -0.6% | -$722 |
|
|
LX
943
LexinFintech Holdings
LX
$1.01B
| $115K | ﹤0.01% |
7,569
+756
| +11% | +$11.5K |
|
944
Sanofi
SNY
$111B
| $114K | ﹤0.01% |
2,241
-351
| -14% | -$17.9K |
|
|
SAFE
945
DELISTED
Safehold Inc.
SAFE
| $111K | ﹤0.01% |
2,745
+795
| +41% | +$32.1K |
|
946
Novartis
NVS
$249B
| $109K | ﹤0.01% |
1,146
-145
| -11% | -$13.8K |
|
|
IMMU
947
DELISTED
Immunomedics Inc
IMMU
| $109K | ﹤0.01% |
5,526
-1,337
| -19% | -$26.4K |
|
|
CUB
948
DELISTED
Cubic Corporation
CUB
| $108K | ﹤0.01% |
1,656
-159
| -9% | -$10.4K |
|
949
Ligand Pharmaceuticals
LGND
$3.27B
| $107K | ﹤0.01% |
1,690
+137
| +9% | +$8.67K |
|
|
HT
950
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $107K | ﹤0.01% |
7,645
| – | – |
|